Orthopedic Biomaterials | Europe (Supplemental) | 2015 | Market Analysis
Despite recent and ongoing obstacles to growth, including considerable economic difficulties and a deteriorating reimbursement environment, the European orthopedic biomaterial market will show moderate expansion through 2023 as favorable demographics contribute to procedure volume growth that will offset downward pricing pressures.
This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the orthopedic biomaterials market in Europe, including country-level data for 20 major countries and aggregate data for the rest of Europe, across a 10-year period.
